// App-Quantinova.ai

1732 : Cost-Effectiveness Of Antithrombin Repletion In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy; A Single Center Experience

Researchers

Presenter

  • Kristen B. McCullough

Principal Investigators

  • Jason N. Barreto

  • Candy S Peskey

  • Dennis A. Gastineau

  • Michelle Elliott

  • Naseema Gangat

  • Mrinal M Patnaik

  • Mark Litzow

  • William J Hogan

Medical Centers

  • Department of Oncology, Mayo Clinic, Rochester, MN

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Pegaspargase

  • Oncaspar

  • Asparaginase

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • observational

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved